Infection Surveillance Solutions Market Share

North America Market Statistics

North America infection surveillance solutions market is anticipated to account for revenue share of more than 34.5% by the end of 2037. The market is expanding due to the rising costs of HAIs, growing provider consolidation, and the increased use of healthcare IT solutions to reduce rising healthcare costs. Office of the National Coordinator for Health IT stated that nearly all non-federal acute care hospitals (96%) and 4 out of 5 office-based physicians (78%) had implemented certified electronic health records by 2021.

Federal rules for the adoption of clinical surveillance systems have led to an increasing number of hospitals and healthcare facilities in the U.S. implementing infection monitoring systems. According to the Office of Disease Prevention and Health Promotion, every year, over 680,000 illnesses and billions of dollars in additional healthcare expenses are incurred nationwide due to healthcare-associated infections (HAIs). In hospitals alone, one in every thirty-one hospitalized patients has at least one HAI at any given moment. Therefore, with infection surveillance software healthcare facilities can quickly detect infections.

In Canada, the growing prevalence of surgical site infections due to the increased number of surgeries is escalating the infection surveillance solutions market growth. Surgical site infections (SSIs) are thought to impact between 26,000 and 65,000 individuals in Canada each year.

Europe Market Analysis

The infection surveillance solutions market in Europe is expected to witness significant growth during the forecast period. The infection surveillance solutions market growth can be credited to the increasing prevalence of chronic diseases which has increased the number of surgical procedures in the region. EFPIA reported that 37% of Europeans 65 years of age and older suffer from several chronic illnesses; nevertheless, the percentage varies nearly threefold within EU member states.

In the UK, the adoption of infection surveillance solutions in healthcare settings is driven primarily by increased awareness of infection control sparked by events such as the COVID-19 pandemic. Tight regulatory mandates and technological advancements like artificial intelligence and big data analytics are also contributing factors.

Germany is implementing cutting-edge technologies, such as artificial intelligence (AI), to identify patterns in the virus's dissemination and prevent it from spreading. Researchers in this country are concentrating on creating a novel approach to infection surveillance so that it may be completed more quickly and effectively.